Výsledky vyhledávání - "Patrick Morre"

Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg—a report from the AGMT COVID-19 Registry

Autor: Alexander Egle, Gabriel Rinnerthaler, Stefanie Fleimisch, Florian Huemer, Richard Greil, Iris Kremser, Hannes Oberkofler, Patrick Morre, Benedikt Jörg, Elisabeth Proksch, Birgit Stegbuchner

Publikováno v: GeroScience

COVID-19-associated case fatality rates up to 48% were reported among nursing facility residents. During the first wave of the COVID-19 pandemic, routine SARS-CoV-2 testing in long-term care facilities in the Province of Salzburg and centralized hosp

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d019e98beb988cb21b1761b3b9e82cf8
http://europepmc.org/articles/PMC8035610

Zobrazit plný text záznamu

Sequential immunotherapy in a patient with primary refractory Hodgkin lymphoma and novel mutations

Autor: Bettina Jansko, Lisa Pleyer, Daniel Neureiter, Christoph Rass, Carmen Feierabend, Lukas Rettenbacher, Richard Greil, Olga Stiefel, Patrick Morre, Sigrun Greil-Ressler

Publikováno v: Oncotarget

Primary resistant Hodgkin lymphoma is an aggressive disease with few treatment options and short survival. Neoplastic cells of classical Hodgkin lymphoma are heavily dependent on microenvironmental stimuli, regularly express PD-L1, and a relevant pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5d89ea799bf4f7e1e2d8bd52a132e6a
http://europepmc.org/articles/PMC5945535

Zobrazit plný text záznamu

Endothelin-1 genetic polymorphism as predictive marker for bevacizumab in metastatic breast cancer

Autor: Cornelia Hauser-Kronberger, Hubert Hackl, S Brechelmacher, Florian Huemer, Clemens Hufnagl, C. Monzo Fuentes, Richard Greil, Franz Romeder, Brigitte Mlineritsch, Gabriel Rinnerthaler, Patrick Morre, Simon Peter Gampenrieder

Publikováno v: The Pharmacogenomics Journal. 17:344-350

Biomarkers for bevacizumab efficacy in metastatic breast cancer (MBC) are of urgent need. The genetic variability of genes involved in angiogenesis could explain the interpatient variability of drug effects. For this biomarker study DNA was extracted

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0fa01dd860fd9cb9cfee8163c979e5d1
https://doi.org/10.1038/tpj.2016.25

Zobrazit plný text záznamu

Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics

Autor: Richard Greil, Lisa Pleyer, Georg Hopfinger, Susanne Steinkirchner, Ann Boekstegers, Daniel Neureiter, Jutta Auberger, Alexander Egle, Ralf Kemmerling, Patrick Morre, Clemens Hufnagl, Lukas Weiss, Thomas Melchardt

Publikováno v: Leukemia & Lymphoma. 56:353-360

Clinical and/or biological risk factors are needed to identify elderly patients with aggressive B-cell lymphoma able to receive full-dose R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine, prednisone) treatment. We present a retrospective

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::48afc5dd7a43ff2d817423a2f70c9fad
https://doi.org/10.3109/10428194.2014.916798

Zobrazit plný text záznamu

Abstract P6-08-47: Androgen receptor expression in pre-menopausal early breast cancer patients treated with endocrine therapy within the ABCSG-12 trial - a single center pilot analysis

Autor: Brigitte Mlineritsch, Patrick Morre, Anna M Knopp, Richard Greil, Christian Fesl, Michael Gnant, Gabriel Rinnerthaler, Cornelia Hauser-Kronberger, Simon Peter Gampenrieder

Publikováno v: Cancer Research. 75:P6-08

Background: Estrogen-receptor (ER) positive breast cancer co-expresses androgen receptor (AR) in 75% to 95% of cases. The Austrian Breast & Colorectal Cancer Study Group (ABCSG) trial 12 compared anastrozole plus goserelin with tamoxifen plus goserel

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::542ffed3d46e3ce844f45e5038d01b19
https://doi.org/10.1158/1538-7445.sabcs14-p6-08-47

Zobrazit plný text záznamu

Treatment of Aggressive B-Cell Lymphoma in the Elderly: The Influence of SNPs Affecting Pharmacodynamics Is Different Compared to Younger Patient

Autor: Daniel Neureiter, Ralf Kemmerling, Ann Boekstegers, Georg Hopfinger, Lukas Weiss, Thomas Melchardt, Alexander Egle, Patrick Morre, Clemens Hufnagl, Richard Greil

Publikováno v: Blood. 120:1613-1613

Abstract 1613 Background: Elderly patients with aggressive B-cell lymphoma are underrepresented in almost all clinical trials and treatment related toxicity mainly due to anthracycline treatment is a major concern. Individual pharmacogenetic settings

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9bfa9f43f94ef217667a65e654a213bf
https://doi.org/10.1182/blood.v120.21.1613.1613

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání